Beneficial and detrimental aspects of miRNAs as chief players in breast cancer: a comprehensive review

A Ismail, HA El-Mahdy, AI Abulsoud… - International Journal of …, 2023 - Elsevier
Breast cancer (BC) is the most common cancer in women and poses a serious threat to their
health. Despite familiarity with factors affecting its etiology, initiation, progression, treatment …

[HTML][HTML] MicroRNAs in apoptosis, autophagy and necroptosis

Z Su, Z Yang, Y Xu, Y Chen, Q Yu - Oncotarget, 2015 - ncbi.nlm.nih.gov
MicroRNAs (miRNAs) are endogenous 22 nt non-coding RNAs that target mRNAs for
cleavage or translational repression. Numerous miRNAs regulate programmed cell death …

[HTML][HTML] miR-134 in extracellular vesicles reduces triple-negative breast cancer aggression and increases drug sensitivity

K O'Brien, MC Lowry, C Corcoran, VG Martinez… - Oncotarget, 2015 - ncbi.nlm.nih.gov
Exosomes (EVs) have relevance in cell-to-cell communication carrying pro-tumorigenic
factors that participate in oncogenesis and drug resistance and are proposed to have …

Novel insights into the roles of Rho kinase in cancer

L Wei, M Surma, S Shi, N Lambert-Cheatham… - Archivum immunologiae …, 2016 - Springer
Rho-associated coiled-coil kinase (ROCK) is a major downstream effector of the small
GTPase RhoA. The ROCK family, consisting of ROCK1 and ROCK2, plays a central role in …

[HTML][HTML] Targeting oncomiRNAs and mimicking tumor suppressor miRNAs: Νew trends in the development of miRNA therapeutic strategies in oncology

R Gambari, E Brognara… - … journal of oncology, 2016 - spandidos-publications.com
MicroRNA (miRNA or miR) therapeutics in cancer are based on targeting or mimicking
miRNAs involved in cancer onset, progression, angiogenesis, epithelial-mesenchymal …

miRNA expression profiling of 51 human breast cancer cell lines reveals subtype and driver mutation-specific miRNAs

M Riaz, MTM van Jaarsveld, A Hollestelle… - Breast cancer …, 2013 - Springer
Introduction Breast cancer is a genetically and phenotypically complex disease. To
understand the role of miRNAs in this molecular complexity, we performed miRNA …

Anoikis resistance––protagonists of breast cancer cells survive and metastasize after ECM detachment

Y Dai, X Zhang, Y Ou, L Zou, D Zhang, Q Yang… - Cell Communication and …, 2023 - Springer
Breast cancer exhibits the highest global incidence among all tumor types. Regardless of
the type of breast cancer, metastasis is a crucial cause of poor prognosis. Anoikis, a form of …

MSC-regulated microRNAs converge on the transcription factor FOXP2 and promote breast cancer metastasis

BG Cuiffo, A Campagne, GW Bell, A Lembo, F Orso… - Cell stem cell, 2014 - cell.com
Mesenchymal stem/stromal cells (MSCs) are progenitor cells shown to participate in breast
tumor stroma formation and to promote metastasis. Despite expanding knowledge of their …

RAS-MAPK pathway epigenetic activation in cancer: miRNAs in action

J Masliah-Planchon, S Garinet, E Pasmant - Oncotarget, 2015 - pmc.ncbi.nlm.nih.gov
The highly conserved RAS-mitogen activated protein kinase (MAPK) signaling pathway is
involved in a wide range of cellular processes including differentiation, proliferation, and …

Role of miRNAs in tumor and endothelial cell interactions during tumor progression

F Orso, L Quirico, D Dettori, R Coppo, F Virga… - Seminars in Cancer …, 2020 - Elsevier
Cancer is a multistep disease based on crucial interactions between tumor cells and the
microenvironment (extracellular matrix and stroma/immune cells). In fact, during …